Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-31

FDA Approved: FENTANYL TRANSDERMAL — Supplemental Application (SpecGx LLC)

View source ↗

Summary

FDA approved a supplemental application for fentanyl transdermal from SpecGx LLC. The approval represents a modification to the existing product's approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fentanyl transdermal (fentanyl transdermal system)

Snippet

SUPPL AP for FENTANYL TRANSDERMAL (FENTANYL TRANSDERMAL)